Semaglutide authorised as Ozempic is not currently recognised by regulators as causing specific vulvovaginal adverse reactions such as vaginal dryness, vulvovaginal candidiasis, altered discharge, dyspareunia, vaginal atrophy, or vaginal mucosal injury
Consumers should discuss realistic expectations, risks, and alternatives with a licensed healthcare provider before starting any prescription weight-management medication
Los potenciadores naturales de GLP-1 representan una estrategia basada en la alimentacin para optimizar la produccin endgena de esta hormona metablica clave
During the initial period of using any new transdermal medication, patients may experience local skin reactions such as mild redness, itching, or irritation at the application site
But things definitely taste different to her
Your care management, provider messaging, and support access all run through that app